QA: Enveric Biosciences Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000890821_2025_Enveric_Biosciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0000890821', 'EntityCommonStockSharesOutstanding': 596978, 'Assets': 5095941, 'AssetsCurrent': 4936707, 'ComprehensiveNetIncome': -8757508, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 918400, 'LiabilitiesAndStockholdersEquity': 5095941, 'LiabilitiesCurrent': 918400, 'LiabilitiesNoncurrent': 0, 'NetIncome': -8771987, 'PropertyPlantAndEquipmentNet': 159234, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'TemporaryEquity': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 14479, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 4177541, 'remainder_NetIncome': -8771987, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}

Graph

Absolute values for 0000890821, Enveric Biosciences Inc

  xvar xval
0 AssetsCurrent 2,734,584
1 IntangibleAssetsNetIncludingGoodwill 42,182
2 PropertyPlantAndEquipmentNet 305,777
3 remainder_Assets 0
4 LiabilitiesCurrent 1,489,736
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 0
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 14,752
11 remainder_Revenues 0
12 remainder_NetIncome -11,920,668
13 remainder_ComprehensiveNetIncome -24,226
  yvar yval
0 Assets 3,082,543
1 Liabilities 1,489,736
2 Expenses 14,752
3 Revenues 0
4 StockholdersEquity 1,592,807
5 NetIncome -11,935,420
6 ComprehensiveNetIncome -11,947,533
7 BaseVar 8,265,962
8 EconomicCapitalRatiobeforeLimitedLiability -3.71
9 EconomicCapitalRatio 0.470

Edgar->Model Mapping

Feature Distribution

Change over Time